Efficacy and safety of tiotropium Respimat(®) SMI in COPD in two 1-year randomized studies

Two 1-year studies evaluated the long-term efficacy and safety of tiotropium 5 or 10 μg versus placebo, inhaled via the Respimat(®) Soft Mist™ Inhaler (SMI). The two studies were combined and had 4 co-primary endpoints (trough FEV(1) response, Mahler Transition Dyspnea Index [TDI] and St George’s Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Bateman, Eric, Singh, Dave, Smith, David, Disse, Bernd, Towse, Lesley, Massey, Dan, Blatchford, Jon, Pavia, Demetri, Hodder, Rick
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921687/
https://www.ncbi.nlm.nih.gov/pubmed/20714373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921687/
https://www.ncbi.nlm.nih.gov/pubmed/20714373

Ejemplares similares